A Tandem Heck-Carbocyclization/
Suzuki-Coupling Approach to the
Stereoselective Syntheses of Asymmetric
3,3-(Diarylmethylene)indolinones
Wing S. Cheung, Raymond J. Patch, and
Mark R. Player*
FIGURE 1. Indolinone-based kinase inhibitors.
Drug Discovery, Johnson & Johnson Pharmaceutical
Research and Development, L.L.C., 8 Clarke Drive,
Cranbury, New Jersey 08512
Only a limited number of medicinally relevant 3-(di-
arylmethylenyl)indolinones have been disclosed. These
tend to be symmetrically substituted derivatives such as
3-[bis(4-methoxyphenyl)methylene]-1,3-dihydroindol-2-
one, which are readily accessible by condensation reac-
tions between an oxindole and a symmetrical diaryl
ketone, bis-(4-methoxyphenyl)methanone.5
Received January 4, 2005
Performing this intermolecular condensation with an
unsymmetrical diaryl ketone would be expected to give
rise to a mixture of both geometrical isomer products,
absent overriding directing group effects. The lack of a
general method for the synthesis of unsymmetrically
substituted 3-(diarylmethylenyl)indolinone isomers may
partially explain why these systems have not been more
extensively investigated. Herein, we report the develop-
ment of a versatile stereoselective synthesis of asym-
metric 3-(diarylidenyl)indolinones, 2. Our method in-
volves a two-step tandem Heck-carbocyclization/Suzuki-
coupling process starting from 2-iodoanilines and aryl-
propionic acids.6
An efficient and versatile method for stereoselective syn-
thesis of (E)-3,3-(diarylmethylene)indolinones by a pal-
ladium-catalyzed tandem Heck-carbocyclization/Suzuki-
coupling sequence is presented. Factors influencing yield and
selectivity, namely catalyst, coordinating ligand, and solvent,
are detailed.
To introduce asymmetry at the exocyclic methylene
carbon, we sought a method by which two aryl groups
could be incorporated at this site independent of one
another. Retrosynthetically (Scheme 1) we envisioned a
process wherein an intramolecular Heck-carbocyclization
of an arylpropynamide 5 might favor a single (E)-
vinylpalladium intermediate, 4. Subsequent coupling
with an aryl boronic acid 3 would serve to incorporate
the second aryl substituent in a stereoselective fashion,
provided that this kinetic vinylpalladium species would
resist isomerization to the thermodynamic (Z)-configu-
ration under conditions of the reaction. Arylpropyna-
mides 5 in turn, would be readily accessible from
arylpropynoic acids (6) and 2-iodoanilines (7) (Table 1).
Unsubstituted phenylboronic acid was initially chosen
in order to test the feasibility of this sequence and for
carrying out a cursory probe of coupling conditions. Thus,
phenylpropiolic acid (6) was converted to its acid chloride
The 2-indolinone system has been incorporated in a
significant number of pharmaceutically relevant com-
pounds. Potential utilities for such compounds have been
identified in virtually all of the major therapeutic areas
including oncology, inflammation, CNS, immunology, and
endocrinology. Indolinones bearing a substituted exocy-
clic methylene at the 3-position have gained particular
prominence in the fields of oncology and inflammation,
as this pharmacophore has demonstrated a unique ability
to inhibit kinase activities through a competitive interac-
tion at the ATP binding sites of these enzymes. While
many 3-(arylidenyl)indolinone analogues have been ex-
tensively evaluated for kinase inhibitory activities, these
have by and large been monoaryl-substituted methyli-
denyl analogues, e.g., SU66681 and SU11248 (Figure 1).2
3-(Arylaminomethylenyl)indolinones have also been iden-
tified as potent kinase inhibitors. As exemplified by GW-
491619, these have also largely been trisubstituted
olefinic derivatives.3 One notable exception is the recently
identified Aurora B inhibitor, hesperadin (1), in which
the exocyclic olefin is tetrasubstituted.4
(3) (a) Eberwein, D. J.; Harrington, L.; Griffin, R.; Tadepalli, S.;
Knick, V.; Phillips, K.; Dickerson, S.; Davis, S. Proc. Am. Assoc. Cancer
Res. 2002, 43: Abst 1611. (b) Davis, S. T.; Dickerson, S. H.; Harris, P.
A.; Hunter, R. N.; Kuyper, L. F.; Luzzio, M. J.; Veal, J. M.; Walker, D.
H. US Pat. 6,387,919, 2002.
(4) Hauf, S.; Cole, R. W.; LaTerra, S.; Zimmer, C.; Schnapp, G.;
Walter, R.; Heckel, A.; van Meel, J.; Rieder, C. L.; Peters, J. M. J. Cell
Biol. 2003, 161, 281-94.
(5) Sato, A.; Asao, T.; Hagiwara, Y.; Kitade, M.; Yamazaki, Y. US
Pat. 5,965,600, 1999.
(1) (a) Sun, L.; Liang, C.; Shirazian, S.; Zhou, Y.; Miller, T.; Cui, J.;
Fukuda, J. Y.; Chu, J. Y.; Nematalla, A.; Wang, X.; Chen, H.; Sistla,
A.; Luu, T. C.; Tang, F.; Wei, J.; Tang, C. J. Med. Chem. 2003, 46,
1116-9. (b) Sun, L.; Tran, N.; Liang, C.; Hubbard, S.; Tang, F.; Lipson,
K.; Schreck, R.; Zhou, Y.; McMahon, G.; Tang, C. J. Med. Chem. 2000,
43, 2655-63.
(2) Mendel, D. B.; Laird, A. D.; Xin, X.; Louie, S. G.; Christensen,
J. G.; Li, G.; Schreck, R. E.; Abrams, T. J.; Ngai, T. J.; Lee, L. B.;
Murray, L. J.; Carver, J.; Chan, E.; Moss, K. G.; Haznedar, J. O.;
Sukbuntherng, J.; Blake, R. A.; Sun, L.; Tang, C.; Miller, T.; Shirazian,
S.; McMahon, G.; Cherrington, J. M. Clin. Cancer Res. 2003, 9, 327-
37.
(6) While this paper was in preparation, Yanada et al. published a
complementary method for the syntheses of 3-diarylmethylidenylox-
indoles involving tandem indium carbometalation and palladium-
catalyzed coupling reactions. The applicability of their method with
N-containing heterocycles was not presented. Yanada, R.; Obika, M.;
Takemoto, Y. Org. Lett. 2004, 6, 2825-2828.
10.1021/jo050016d CCC: $30.25 © 2005 American Chemical Society
Published on Web 04/02/2005
J. Org. Chem. 2005, 70, 3741-3744
3741